Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma — Kligman

Melanosis Clinical Trial

Official title:
Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma: a Double Blind Prospective Randomzed Study

Status Completed

Clinical Trial Summary

Kligman's trio remains the gold standard treatment for melasma. It contain hydroquinone which is an effective anti-melanogenic compound but that has poor tolerance and numerous side-effects. Thiamidol has been proven to be at least as effective as hydroquinone and has a very good safety profile. The objective of this study is to compare the Kligman's trio to the same preparation in which hydroquinone is replaced by thiamidol.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Melanosis

Clinical Trial Details

NCT number	NCT05119413
Study type	Interventional
Source	Centre Hospitalier Universitaire de Nice
Contact
Status	Completed
Phase	Phase 2
Start date	November 30, 2021
Completion date	December 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01976273` - A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma	N/A
Terminated	`NCT00863278` - Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser	Phase 4
Recruiting	`NCT00927771` - Azelaic Acid Versus Hydroquinone in Melasma	Phase 4
Not yet recruiting	`NCT05930392` - Comparative Evaluation of Microsurgery vs Conventional Surgical Technique of Gingival Depigmentation	N/A
Not yet recruiting	`NCT05930366` - Comparative Evaluation of Microsurgery vs Diode Laser Technique of Gingival Depigmentation	N/A
Active, not recruiting	`NCT01976286` - A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma	N/A
Not yet recruiting	`NCT03585179` - Oral and Topical Tranexamic Acid for the Treatment of Melasma	Phase 3